资讯 | 中国3月制造业 PMI 大幅回升至 52%。中国央行时隔 29 日重启逆回购

资讯摘要

美美股周一收高,三大股指涨幅均超过 3%,道指涨逾 690 点。投资者继续追踪冠状病毒的传播状况及其经济影响。原油期货价格创 18 年新低。中国央行时隔 29 日重启逆回购,利率下调至2.20%。4 月降息可期。

 

 

美股资讯

北京时间3月31日凌晨,美股周一收高,三大股指涨幅均超过3%,道指涨逾690点。投资者继续追踪冠状病毒的传播状况及其经济影响。原油期货价格创18年新低。截止收盘,道指涨690.70点,或3.19%,报22327.48点;纳指涨271.77点,或3.62%,报7774.15点;标普500指数涨85.18点,或3.35%,报2626.65点。

道指成分股当中,医药与科技股领涨。强生公司收高8.00%,默沙东集团收高7.28%,微软公司收高7.03%,英特尔公司收高5.96%,卡特彼勒收高5.95%,辉瑞制药收高5.73%。特斯拉跌超2%。

市场仍在消化美国2万亿美元刺激方案,美联储前期推行了降息至零、无限QE等前所未有的宽松措施,但未来操作空间已经不大。分析师称,现在轮到财政刺激政策上阵,目的仍是避免疫情对经济造成更大的伤害。

疫情蔓延形势严峻 特朗普延长隔离指引

新冠肺炎疫情在美国持续蔓延,该国已成为全球新冠肺炎确诊病例最多的国家。美国《纽约时报》28日的一篇文章分析称,美国政府未能在早期进行大规模检测,错失遏制新冠病毒传播的最佳机会。

周日,美国总统特朗普在新闻发布会上表示,他延长了市民社交距离行为指引的执行时间,指导市民在4月30日之前保持社交距离。此前特朗普曾表示他希望在4月中旬复活节之前使美国恢复经济活动。

其他一些国家最近也延长了社交隔离时间表,以遏制冠状病毒疫情的蔓延。英国的封锁期已进入第二周,英国政府官员表示,他们认为封锁一共可能会持续长达6个月。据地区新闻媒体周一报道,日本准备禁止最近去过美国、加拿大、韩国和欧洲大部分地区的外国人入境。

焦点个股

美国联合航空、美国航空集团及达美航空等航空股持续下挫。

西方石油、雪佛龙、英国石油等石油股走弱。

雅培公司宣称推出检测方案,可最快在五分钟内检测出COVID-19的阳性结果,该方案已获得FDA紧急批准。

强生宣布新冠病毒的主要候选疫苗。强生与美国卫生及公共服务部下属的生物医学高级研究与开发局承诺将提供超过10亿美元以支持疫苗研发。

 

 

港股资讯

北京时间3月30日,美股周五收跌。道指下跌超过900点,结束三连涨,但该指数创下1938年以来的最大单周涨幅。美众院通过2万亿美元刺激计划。美国已成全球确诊新冠肺炎病例最多的国家。继上周大幅上涨后,美国股指期货周日晚间低开,美国新冠病毒病例数量继续以惊人的速度上升。恒指期货日盘开跌2.77%,报22860点。周一开盘,恒生指数低开1.97%,午后跌幅一度收窄至翻红。截止收盘,恒生指数跌1.32%,报23175.11点;国企指数跌1.08%;红筹指数跌1.4%。

热点板块

内地医药股上涨。华润医疗涨5.85%;威高股份涨4.74%;联邦制药涨4.2%。

苹果概念股下跌。舜宇光学跌4.86%;瑞声科技跌2.98%;丘钛科技跌3.65%。

内房股下跌。融创中国跌6.38%;新城发展跌4.06%;中国恒大跌3.88%。

石油股下跌。中海油田服务跌6.6%;中国海洋石油跌2.57%;昆仑能源跌3.27%。

濠赌股下跌。金沙中国跌4.92%;银河娱乐跌4.81%;永利澳门跌3.41%。

 

 

中国A股资讯

北京时间3月30日,早盘两市指数低开低走,创业板指快速跌逾3%。盘面上,农业种植板块逆势走强,科技股持续走弱,市场无绝对热点,资金情绪较为低迷,多头反攻无力,赚钱效应差。临近上午收盘,指数表现持续弱势,板块方面,两市仅有医药、农业板块表现强势,前期热点集体回调。炸板率持续走高,题材板块普跌,市场观望情绪浓厚,抄底资金连续被埋,赚钱效应较差。午后,指数小幅回升,沪指跌幅收窄至1%,创指、深成指跌幅显著收窄。盘面上,特高压概念再度异动,北向资金午后转为流入。总体上,市场积极情绪悄然恢复,赚钱效应有转好势头。尾盘,指数再度回落后继续盘整。盘面上,半导体等科技题材走强,中船系带领军工板块拉升,资金情绪一般,两市个股依旧普跌。截止收盘,沪指报2747.21点,跌0.90%,成交额为2507亿元;深成指报9904.95点,跌2.03%,成交额为3824亿元。

从盘面上看,中船系、种植业、磷化工居板块涨幅榜前列,云办公、景点旅游、网络安全跌幅榜前列。

热门板块

中船系概念股走强,中船防务、中国动力、中船科技、中国船舶、久之洋、中国应急等个股表现活跃。

消息面上有机构表示,近期军工基本面继续好转:从行业景气周期和军费开支节奏来看,预计2020年军工行业景气上行,整体业绩和订单预期有望进一步提升。

农业种植板块恒强,金健米业、农发种业、苏垦农发、新赛股份、登海种业、新农开发、北大荒等跟涨。

消息面上分析人士表示,受产业供需影响,部分农产品确实迎来了周期风口,疫情带来的外部供应变化短期也会对部分农产品价格带来影响,但整体而言,国内农产品市场供应充足稳定,不会出现脱销断档现象。

“降息”20BP!央行时隔29日重启逆回购 利率下调至2.20%

3月30日,人民银行发布公开市场业务交易公告称,为维护银行体系流动性合理充裕,2020年3月30日人民银行以利率招标方式开展了500亿元逆回购操作,期限为7天,中标利率为2.20%。

这距离央行上次开展逆回购操作已有29个工作日。更值得注意的是,此次7天逆回购操作中标利率较上次2.40%下调了20个基点。

进一步加大逆周期调节力度

时隔一个多月,央行再度下调逆回购利率,而相比2月初逆回购利率下调10个基点,此次“降息”幅度进一步扩大。

“此次公开市场操作中标利率下降20个基点标志着央行进一步加大逆周期调节力度。”央行货币政策委员会委员、清华大学国家金融研究院研究员马骏表示,“选择在这个时点‘降息’,应该是综合考虑了国内复工复产需求以及国际疫情和外部经济环境恶化等多方面因素后做出的决策。

3月份中国制造业PMI回升至52%

3月31日国家统计局服务业调查中心、中国物流与采购联合会31日发布数据,3月份,中国制造业采购经理指数为52%,比上月回升16.3个百分点。

从企业规模看,大、中、小型企业PMI分别为52.6%、51.5%和50.9%,比上月回升16.3、16和16.8个百分点。从分类指数看,在构成制造业PMI的5个分类指数中,生产指数、新订单指数和从业人员指数均升至临界点之上,原材料库存指数和供应商配送时间指数低于临界点。

国家统计局服务业调查中心负责人表示,3月份采购经理指数较2月份明显上升反映当前多数企业随着复工复产的有序推进,企业生产经营情况比上月有所改善,但并不意味着企业的实际生产经营已恢复至疫情前水平。通常情况下,当PMI连续三个月以上同向变化时,才能反映经济运行的趋势性变化,仅仅单月数据升至荣枯线上,并不能判断我国经济已完全恢复正常水平、实现趋势性好转,还需持续观察变化。

 

如果有想了解更多全球股市资讯,请关注微信公众号 “辉立资本新加坡” (SGPSPL)。同时提供在线免费开设股票账户,一个账户轻松交易全球股票和ETF

美股,港股,新加坡股,中国A股,越南股票,韩国股票,德国股票,马来西亚股票,泰国股票,印尼股票,菲律宾股票,日本股票,澳大利亚股票,台湾股票,加拿大股票,英国股票,法国股票,荷兰股票,葡萄牙股票,比利时股票,土耳其股票

如果本文是英文翻译版本,一切请以英文为准

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com